MustGrow Biologics Corp. (OTC:MGROF – Get Free Report) rose 4.1% on Wednesday . The stock traded as high as C$0.87 and last traded at C$0.87. Approximately 150 shares changed hands during trading, a decline of 84% from the average daily volume of 936 shares. The stock had previously closed at C$0.84.
MustGrow Biologics Stock Performance
The company has a 50-day moving average of C$0.94 and a two-hundred day moving average of C$1.00.
About MustGrow Biologics
MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets.
Read More
- Five stocks we like better than MustGrow Biologics
- How to Use the MarketBeat Stock Screener
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Stock Market Upgrades: What Are They?
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Do ETFs Pay Dividends? What You Need to Know
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for MustGrow Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MustGrow Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
